Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $629.06M | 80,032,823 | 63.09% | 36.91% | Net Buying | Net Selling | ||
| TYRA | TYRA BIOSCIENCES INC | $1.77B | 53,867,115 | 62.42% | 37.58% | Net Buying | Net Selling | ||
| KGC | KINROSS GOLD CORP | $36.32B | 1,194,109,463 | 58.97% | 0.00% | ||||
| VKTX | VIKING THERAPEUTICS INC | $3.67B | 116,105,643 | 61.96% | 8.85% | Net Selling | Net Buying | ||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | N/A | 34,748,841 | 0.00% | 24.51% | Net Selling | Net Selling | ||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $155.83M | 57,288,750 | 65.18% | 34.82% | Net Buying | Net Buying | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.59B | 80,015,667 | 34.80% | 65.20% | Net Selling | Net Selling | ||
| BLLN | BILLIONTOONE INC | $4.27B | 45,995,484 | 18.59% | 25.94% | Net Buying | |||
| LBRX | LB PHARMACEUTICALS INC | $917.02M | 28,674,827 | 76.06% | 23.94% | Net Buying | |||
| DNLI | DENALI THERAPEUTICS INC | $3.13B | 158,591,491 | 62.97% | 37.03% | Net Selling | |||
| NYXH | NYXOAH SA | $137.68M | 43,026,460 | 8.61% | 0.00% | ||||
| NEXN | NEXXEN INTERNATIONAL LTD | $217.54M | 56,284,083 | 65.34% | 2.70% | ||||
| CLYM | CLIMB BIO INC | $681.97M | 57,260,523 | 54.53% | 10.97% | Net Buying | Net Selling | ||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.34B | 114,883,096 | 60.18% | 39.82% | Net Buying | Net Selling | ||
| VIST | VISTA ENERGY SAB DE CV | $6.92B | 105,186,958 | 43.84% | 10.80% | Net Selling | Net Selling | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.48B | 87,860,920 | 92.66% | 7.34% | Net Buying | Net Buying | ||
| CLSK | CLEANSPARK INC | $3.58B | 255,752,913 | 74.93% | 25.07% | Net Selling | Net Selling | ||
| EVER | EVERQUOTE INC | $728.69M | 35,373,278 | 59.49% | 40.51% | Net Selling | Net Selling | ||
| SLDB | SOLID BIOSCIENCES INC | $695.63M | 98,391,314 | 55.24% | 44.76% | Net Selling | Net Selling | ||
| PCVX | VAXCYTE INC | $7.43B | 144,397,682 | 88.01% | 11.99% | Net Selling | Net Selling | ||
| CGEM | CULLINAN THERAPEUTICS INC | $890.94M | 60,526,128 | 56.33% | 43.67% | Net Buying | Net Selling | ||
| SEPN | SEPTERNA INC | $1.08B | 44,906,374 | 66.75% | 33.25% | Net Buying | Net Buying | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $410.16M | 113,933,436 | 23.17% | 76.83% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.